C07D 501/24
With hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in
Official title: with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
C07D501/24 (With hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in) appears on 586 US grants and 145 published applications in this corpus.
Search patents in C07D- Granted patents
- 586
- Published applications
- 145
- Assignees
- 155
- Inventors
- 908
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 51 | 0 |
| 1977 | 44 | 0 |
| 1978 | 32 | 0 |
| 1979 | 35 | 0 |
| 1980 | 18 | 0 |
| 1981 | 29 | 0 |
| 1982 | 22 | 0 |
| 1983 | 26 | 0 |
| 1984 | 26 | 0 |
| 1985 | 14 | 0 |
| 1986 | 18 | 0 |
| 1987 | 20 | 0 |
| 1988 | 27 | 0 |
| 1989 | 21 | 0 |
| 1990 | 30 | 0 |
| 1991 | 27 | 0 |
| 1992 | 16 | 0 |
| 1993 | 13 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 4 |
| 2004 | 1 | 3 |
| 2005 | 2 | 2 |
| 2006 | 1 | 7 |
| 2007 | 1 | 9 |
| 2008 | 3 | 11 |
| 2009 | 7 | 5 |
| 2010 | 9 | 6 |
| 2011 | 3 | 8 |
| 2012 | 6 | 9 |
| 2013 | 4 | 8 |
| 2014 | 8 | 9 |
| 2015 | 11 | 12 |
| 2016 | 8 | 6 |
| 2017 | 9 | 13 |
| 2018 | 6 | 11 |
| 2019 | 9 | 3 |
| 2020 | 5 | 2 |
| 2021 | 4 | 0 |
| 2022 | 0 | 5 |
| 2023 | 2 | 2 |
| 2024 | 0 | 6 |
| 2025 | 3 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cephalosporin antibacterial compound and preparation method therefor11 Aug 2026US 12,703,709 B2Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Siderophore cephalosporin conjugates and uses thereof29 Jul 2025US 12,371,441 B2Ariva Med GmbH
- Refining method of midbody of latamoxef sodium1 Jul 2025US 12,344,622 B2Hainan Hailing Chemipharma Corporation Ltd.
- β-lactam-cannabinoid conjugate molecules25 Mar 2025US 12,257,307 B2Diverse Biotech, Inc.
- Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same24 Oct 2023US 11,795,491 B2The General Hospital Corporation
- Quorum-sensing inhibitors and/or postbiotic metabolites and related methods7 May 2026US 2026/0124268 A1MicroSintesis Inc.
- Beta-Lactam-Cannabinoid Conjugate Molecules10 Jul 2025US 2025/0222118 A1Diverse Biotech, Inc.
- Metallo-ß-lactamase inhibitors10 Oct 2024US 2024/0335453 A1
- Metallo-beta-lactamase inhibitor25 Jul 2024US 2024/0245783 A1National University Corporation Kumamoto University
- Fluorogenic assay for rapid screening of bacterial beta-lactamase activity18 Jul 2024US 2024/0240226 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Cytotoxic compounds and conjugates121US 7,517,903 B2Medarex, Inc. · 2009
- Fluorogenic substrates for .beta.-lactamase and methods of use85US 5,741,657 AThe Regents of the University of California · 1998
- 3-Acetoxymethyl-7-(iminoacetamido)-cephalosporanic acid derivatives77US 4,152,432 ARoussel Uclaf · 1979
- Cephem compounds63US 4,833,134 ATakeda Chemical Industries, Ltd. · 1989
- 7-[2-(2-Imino-4-thiazolin -4-yl)-2-(syn)-hydroxy-iminoacetamido]-cephalosporins46US 4,264,595 ATakeda Chemical Industries, Ltd. · 1981